agilon health, inc. (NYSE:AGL - Get Free Report) shares saw unusually-high trading volume on Tuesday . Approximately 6,150,804 shares were traded during trading, an increase of 27% from the previous session's volume of 4,856,478 shares.The stock last traded at $3.45 and had previously closed at $3.42.
Analyst Ratings Changes
AGL has been the topic of a number of research analyst reports. JMP Securities lowered shares of agilon health from an "outperform" rating to a "market perform" rating in a report on Monday, November 11th. Sanford C. Bernstein lifted their price target on shares of agilon health from $2.50 to $3.15 and gave the company a "market perform" rating in a report on Wednesday, January 15th. Royal Bank of Canada reiterated an "outperform" rating and issued a $3.00 price target on shares of agilon health in a report on Tuesday, November 19th. Barclays decreased their price target on shares of agilon health from $5.00 to $2.00 and set an "underweight" rating on the stock in a report on Monday, November 11th. Finally, Stifel Nicolaus decreased their price target on shares of agilon health from $7.00 to $2.00 and set a "hold" rating on the stock in a report on Tuesday, November 12th. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $4.03.
View Our Latest Analysis on agilon health
agilon health Stock Performance
The stock's fifty day moving average is $2.82 and its two-hundred day moving average is $3.11. The firm has a market capitalization of $1.45 billion, a price-to-earnings ratio of -3.75 and a beta of 0.67. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.
Insider Activity at agilon health
In other agilon health news, Director John William Wulf bought 45,000 shares of the business's stock in a transaction on Thursday, December 5th. The shares were bought at an average cost of $2.18 per share, with a total value of $98,100.00. Following the transaction, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Karen Mcloughlin bought 25,000 shares of the business's stock in a transaction on Friday, December 13th. The stock was acquired at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the transaction, the director now owns 73,166 shares in the company, valued at $160,965.20. This represents a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders bought 90,000 shares of company stock valued at $198,100. Corporate insiders own 3.20% of the company's stock.
Hedge Funds Weigh In On agilon health
A number of institutional investors have recently made changes to their positions in the business. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of agilon health by 24.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 797,658 shares of the company's stock valued at $1,516,000 after purchasing an additional 157,610 shares in the last quarter. Two Sigma Advisers LP grew its stake in agilon health by 4,393.5% in the fourth quarter. Two Sigma Advisers LP now owns 480,800 shares of the company's stock worth $914,000 after purchasing an additional 470,100 shares in the last quarter. Two Sigma Investments LP grew its stake in agilon health by 73.7% in the fourth quarter. Two Sigma Investments LP now owns 857,867 shares of the company's stock worth $1,630,000 after purchasing an additional 363,855 shares in the last quarter. State of Wyoming grew its stake in agilon health by 89.3% in the fourth quarter. State of Wyoming now owns 122,504 shares of the company's stock worth $233,000 after purchasing an additional 57,802 shares in the last quarter. Finally, Point72 Asset Management L.P. acquired a new position in agilon health in the fourth quarter worth about $768,000.
agilon health Company Profile
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.